FGFR2 and colorectal neoplasm: In another study, FGFR2 (hub gene in Subnetwork 7) is reported to promote the PD-L1 expression via the JAK/STAT3 signaling in colorectal tumors and associated with disease progression and poor survival (Carter et al., 2017; Hu et al., 2019).